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Vertebrate hematopoiesis first produces primitive
(embryonic) lineages and ultimately generates the
definitive (adult) blood. Whereas definitive hemato-
poiesis may produce many diverse blood types via
a common multipotent progenitor, primitive hemato-
poiesis has been thought to produce only erythro-
cytes ormacrophages via progenitors that are unipo-
tent for single blood lineages. Using a variety of
in vivo cell-tracing techniques, we show that primi-
tive blood in zebrafish derives from two different
progenitor types. On the dorsal gastrula, blood
progenitors are unipotential cells that divide infre-
quently, populate the rostral blood islands, and
differentiate into macrophages. In contrast, on the
ventral gastrula, blood progenitors are multipotential
cells with rapid cell cycles; populate the intermediate
cell mass; and differentiate into erythrocytes, neutro-
phils, and thrombocytes. Our results demonstrate
the existence of primitive hematopoietic progenitors
that are segregated very early in development and
that are specified to produce either a unipotent or
a multipotent blood cell lineage.
INTRODUCTION
Hematopoiesis in vertebrates occurs in two successive waves
known as primitive (embryonic) and definitive (adult) (reviewed
in Godin and Cumano, 2002). One of the hallmarks of vertebrate
hematopoiesis is that blood cells are produced in ever-changing
sites throughout development (Baron, 2003; Keller et al., 1999;
Lacaud et al., 2001; Orkin and Zon, 2008). Hence, where a cell
is produced, and not just when, often defines whether it is
considered primitive or definitive. In mammals, during definitive
hematopoiesis, all blood, composed of a diverse population of
white blood cells (monocytes, granulocytes, and lymphocytes),
red blood cells (erythrocytes), and platelets (thrombocytes), is
thought to derive from a common progenitor termed the hema-
topoietic stem cell (Graf, 2008; Orkin and Zon, 2008; Reya
et al., 2001). In contrast, during primitive hematopoiesis, blood
cells are not thought to originate from a multipotent blood
founder, but rather from individual progenitor cells called heman-744 Developmental Cell 16, 744–755, May 19, 2009 ª2009 Elseviergioblasts, which generate only a single blood cell type along
with endothelial descendents (Baron, 2003; Keller et al., 1999;
Lacaud et al., 2001; Orkin and Zon, 2008).
Histological comparison of peripheral blood and the expres-
sion of homologous genes essential for hematopoiesis show
that zebrafish possess equivalent blood types to those of
mammals. Two cell types, erythrocytes and macrophages
(monocytes), are considered by many to be the only primitive
blood of zebrafish, as in mouse (Berman et al., 2005; Davidson
and Zon, 2004; Onnebo et al., 2004; Palis et al., 1999). However,
in the overlapping interval between primitive hematopoiesis and
the onset of definitive hematopoiesis, initiating somewhere
between 24 and 48 hr (Bertrand et al., 2007; Murayama et al.,
2006; Zhang and Rodaway, 2007), three other cell types appear:
neutrophils (heterophilic granulocytes), thrombocytes, and
lymphocytes.
Studies of gene expression and limited fate mapping show
that the zebrafish blood derives from intermediate mesoderm
(Davidson and Zon, 2004; Rohde et al., 2004), a narrow band
of tissue extending bilaterally along either side of the head and
paraxial mesoderm. The intermediate mesoderm also includes
cells of the future endothelial and pronephric lineages (Liao
et al., 1998; Majumdar et al., 2000). By 12 hr, the hematopoietic
portion of the intermediate mesoderm segregates into the
earliest blood differentiation sites roughly equivalent to the blood
islands of the mammalian yolk sac (Berman et al., 2005; David-
son and Zon, 2004; Onnebo et al., 2004). One site located in
the head (Figure 1A), termed the rostral blood island (RBI),
produces the primitive macrophages that by 18 hr migrate
away from the head and out over the yolk sac, whereupon they
quickly disperse throughout the mesenchyme of the embryo
(Herbomel et al., 1999, 2001; Lieschke et al., 2002). The other
site located in the trunk (Figures 1A–1C), called the intermediate
cell mass (ICM), produces the primitive erythrocytes that migrate
anteriorly toward the yolk sac, whereupon they enter the devel-
oping circulatory system around 26 hr (Detrich et al., 1995;
Liao et al., 2002; Long et al., 1997).
Currently, there is confusion concerning the derivation of
embryonic neutrophils, thrombocytes, and lymphocytes. Gene
expression studies indicate that neutrophils may derive from
the ICM (Bennett et al., 2001; Lieschke et al., 2001, 2002; Thisse
and Thisse, 2004) (Figures 1A and 1B), but it has also been re-
ported that neutrophils derive from primitive macrophage cells
once they exit the RBI (Le Guyader et al., 2007) or, alternatively,
from the posterior blood island (PBI; the portion of ICM behindInc.
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(Bertrand et al., 2007). Regardless, cells having the characteris-
tics of neutrophils are evident throughout circulation by 26 hr
(Bennett et al., 2001; Hall et al., 2007; Lieschke et al., 2001; Ma-
thias et al., 2006; Meijer et al., 2007). Little is known of the origin
of embryonic thrombocytes, as they have no early markers, but
they first appear in circulation around 36 hr (Gregory and Jaga-
deeswaran, 2002). Unlike their mammalian equivalent, they do
not appear to derive from megakaryocytes (Lin et al., 2005).
Lymphocytes have also been reported to originate from the
ICM (Willett et al., 2001), but more recent studies claim that
they originate from one of the initial sites of definitive hematopoi-
esis along the dorsal aorta, before migrating to the developing
thymi (Bertrand et al., 2008).
Figure 1. Characterization of Embryonic
Blood
(A–C) The rostral blood island (RBI) and interme-
diate cell mass (ICM) at 18 hr, visualized with (A)
a myeloid marker, (B) a neutrophil marker, and
(C) an erythroid marker.
(D–F) Individual blood cells at 26 hr, visualized by
in situ hybridization: (D) macrophage cells, (E)
neutrophil cells, and (F) erythrocyte cells.
(G–L) Individual blood cells in the live 30 hr
embryo. Each image is a single frame from
a real-time recording of circulating blood. Elapsed
time is indicated in the lower frame, long arrows
indicate the flow of circulation, and insets show
a 2003-magnified view of specific cells. (G and
H) Neutrophils (n) and circulating erythrocytes (e)
in the (G) viteline vein over the yolk sac and in the
(H) lumen of a tail blood sinus. The arrows in (G1)
indicate individual nuclear lobes of a neutrophil,
and the small arrow in (H) indicates where the
neutrophil anchors itself to the endothelial lumen.
(I) A macrophage (m) patrolling the viteline vein.
The last panel is magnified 2003. (J) A circulating
thrombocyte (t and arrow). (K and L) Unidentified
cells. (K) A large rare cell type (u), arrows in the inset
indicate its diffuse nuclear envelope. A macro-
phage (m) is also visible in (K). (L) A dividing cell
(arrow).
Previous fate mapping studies have
reported that zebrafish blood derives
exclusively from the ventral margin of
the gastrula-stage embryo (an area from
which pronephros and endothelial cells
are also derived). However, in the discus-
sion of a report showing that primitive
macrophages differentiate in the RBI
and have an independent program of
development from the erythrocyte portion
of the blood, Lieschke et al. (2002) specu-
lated that, based upon the known move-
ments of zebrafish cells, the macrophage
precursors could possibly be derived
from a more dorsally located region in
the gastrula. Here, we reexamine the
origin of zebrafish embryonic blood. By
intracellularly labeling single marginal
cells at the blastula stage, and correlating the position of these
clones at varying locations along the dorsoventral axis of late-
blastula- and early-gastrula-staged embryos, we show that
future blood derives from all areas of the margin, including the
dorsal margin. We also show that blood derived from the ventral
margin does not produce only a single cell type, but rather many
ventral blood progenitors are multipotent, with lineages that
include not only primitive erythrocytes, but also embryonic
thrombocytes and neutrophils. These multipotent ventral blood
progenitors eventually populate the site of primitive hematopoi-
esis in the ICM. In contrast, blood derived from the dorsal margin
exclusively produces a single cell type, namely, primitive macro-
phages. The dorsal blood progenitors eventually populate the
site of primitive hematopoiesis within the RBI. This unipotentDevelopmental Cell 16, 744–755, May 19, 2009 ª2009 Elsevier Inc. 745
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potent ventral lineage divide often and continue to produce
erythrocyte and neutrophil progeny after 26 hr. Both unipotent
dorsal and multipotent ventral blood progenitors frequently
share lineages with endothelial cells, but a common progenitor
is not obligatory for blood to form. From clonal analysis calcula-
tions and observations of a mutant that undergoes a cell cycle
arrest, we estimate the number of blood progenitors to be 60
out of the calculated 8000 total number of cells at the early
gastrula stage.
RESULTS
Characterization of Zebrafish Embryonic Blood
Of the five blood types observed in the embryonic zebrafish, only
three populations can be unambiguously identified by gene
expression by 1 day. Erythrocytes specifically express hbbe2
(Brownlie et al., 2003), macrophages express lcp1 (Herbomel
et al., 1999), and neutrophils specifically express mpx (Bennett
et al., 2001; Lieschke et al., 2001). Using these probes, we found
cells that weremorphologically distinguishable from one another
by 26 hr (Figures 1D–1F). Macrophages were large, almost twice
the size of other cells, and had smaller nuclei relative to their size.
In addition, macrophages and neutrophils had irregular cell
shapes and folded nuclei. Erythrocytes were uniform in shape
and had rounded nuclei. Although these markers were chosen
because double labeling studies indicated that each marker
labels unique blood cell populations (Bennett et al., 2001), there
have beena number of recent reports onwhether lcp1onlymarks
macrophage cells (Hall et al., 2007; Le Guyader et al., 2007;
Mathias et al., 2006; Meijer et al., 2007). This is because between
48 and 72 hr, some neutrophil cells seem also to express lcp1.
Because of the discrepancies in the literature concerning gene
marker specificity, we were cautious in using gene expression to
solely identify cell types. Thus, we examined and relied upon the
morphology of individual blood cells in vivo for their identifica-
tion. Blood cells were easiest to observe in circulation at 30 hr
over the yolk sac, before the viteline vein narrowed and dis-
placed anteriorly or in the rostral part of the tail before there
was an artery and vein. We observed five different types of
in vivo cells, three of which correlated with our in situ study.
(1) Macrophages: unmistakable cells often located on the
yolk sac or in the mesenchyme of the head. Their
morphology and dimension (Figure 1I) resembled their
in situ stained counterparts. Macrophages used an amoe-
boid-type of locomotion, as has been reported (Herbomel
et al., 1999), but if quiescent tended to extrude pseudo-
podia (Figure 1K).
(2) Neutrophils: smaller than macrophages, these cells were
often anchored to the vessel wall (Figure 1H). Like their
in situ stained counterparts and Wright-Giemsa stained
adult neutrophils (Bennett et al., 2001; Lieschke et al.,
2001), they possessed a segmented nucleus (Figure 1G1).
(3) Erythrocytes: the predominant cell in circulation, resem-
bling their in situ stained counterparts. In vivo, erythro-
cytes appeared concave and elliptical (Figure 1G).
(4) Thrombocytes: tiny cells with no apparent nucleus
(Figure 1J) (Gregory and Jagadeeswaran, 2002).746 Developmental Cell 16, 744–755, May 19, 2009 ª2009 Elsevier(5) Unidentified: very large uniform cells (compare insets in
Figures 1K and 1G) or cells in division (Figure 1L), these
probably made up less than 5% of the total. We did not
observe anything that resembled a lymphocyte.
Blood Fate and Blood Island Location Are Segregated
in the Early Gastrula
To trace the origin of blood, we intracellularly labeled single cells
with lineage tracer dye in the mid-blastula-stage embryo and
subsequently followed only the deep cell (embryonic) portion
of the clone (Figure 2) as outlined in Experimental Procedures.
In our fate map analyses, we also noted the nonblood identities
of cells contained within our clones, including endothelial
(Figures 3D and 3J) and pronephric cells (Figures 3E and 3K).
Inherent in many models of stem cell identity is the hypothesis
that fate decisions are both hierarchical and sequential. To
determine at what stage individual cells became specified
toward a pronephros versus a hemangioblast versus a hemato-
poietic fate, we cataloged the identity of all labeled cells within
our clones relative to when that deep cell clone was established
(for an explanation, see Experimental Procedures). Segregating
our data into deep cell clones that were either established at
the mid-blastula or the early-gastrula stage allowed us to deter-
mine whether individual labeled cells gave rise to single fates or
multiple fates and whether there was a tendency for particular
identities to group together within the same clone.
In agreement with previous fate map analyses (Kimmel et al.,
1990; Vogeli et al., 2006; Warga and Nu¨sslein-Volhard, 1999),
we found that blood derived from the ventral portion of the
gastrula-stage embryo (Figures 2B and 3G). Without exception,
these ventrally derived cells and their progeny located to the ICM
(Figure 2D) before differentiating initially as primitive erythrocytes
(Figures 2G, 2H, and 3B). We also found that blood derived from
the dorsal portion of the gastrula (Figure 3F). Without exception,
these dorsally derived cells located to the RBI (Figure 2D) before
differentiating as primitive macrophages (Figures 2I and 3A).
Interestingly, macrophage and erythrocyte cells never derived
together from the same labeled precursor cell even though their
fate map territories somewhat overlapped during gastrulation. It
should be noted that often clones containing either macro-
phages or erythrocytes also included labeled endothelial cells
(Figure 3L), suggesting that some blood cells derived from
a precursor that had the characteristics of a hemangioblast.
However, passing through a hemangioblast-like state does not
appear to be an absolute requirement for blood production given
the high frequency of solely blood clones (Figure 3L).
Intermediate Mesoderm Becomes Progressively
Restricted to Single Fates
We found that mid-blastula-derived clones (Table 1; n = 67) only
occasionally gave rise to blood alone (10%; rows 3, 13, and 14;
Table 1). In fact, the most commonly observed clones (27%;
rows2, 11,and12;Table1) containedonly bloodandendothelium
together, not inconsistent with a potential hemangioblast origin.
Mid-blastula clones never gave rise to pronephros alone, but
endothelium and pronephros often derived exclusively together
(13%; row 5; Table 1) from the same clone. A surprising number
of mid-blastula-stage clones included blood, endothelium, andInc.
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Analysis of the Embryonic Blood
(A–G0) (A–C and F–G) Progeny of a single mid-
blastula-labeled cell. (A) The clone at 50% epiboly
(face view), now one deep cell (arrow) and two
EVLs (e) at the margin of the blastoderm; note
that the single deep cell is being viewed through
one of the EVL cells. (B) The clone at the shield
stage (animal pole view), now two deep cells
(arrow) and two EVLs (e) located 180 of arc from
the dorsal midline (d). (C) The clone at the 13-
somite stage (side view), now 11 deep cells (arrow)
in the posterior IMC. The EVL portion of the clone
(e), now periderm, is extraembryonic. (F and G)
The clone at 36 hr, now endothelial cells and circu-
lating blood, which include (F) neutrophils and (G)
erythrocytes. (D and D0) Hematopoietic fate maps.
Graphs depict the location of the same clones at
two different stages of development. (D) 6 hr
gastrula fate map, clones versus dorsoventral
location. The presentation is a side view; dorsal
is oriented toward the right, with clones on the
right projected to the left. Each symbol is the
average location of the deep cell portion of a clone
relative to the margin (tier 0), in units of cell
diameter, and the dorsal midline (0), in degrees of arc. The oversized symbol represents the clone shown in (A)–(C), and the small letters refer to the respective
panel. (D0) 16 hr 14-somite stage fate map, clones versus primitive blood island. The horizontal line through each symbol shows the anteroposterior spread of
each clone. All clones except one also included endothelial cells. (E) 24 hr hematopoietic fate map, fate of clone versus anteroposterior location (RBI, somite
level within the ICM, or PBI). Each symbol represents a single clone at that anteroposterior location; however, clones that spread over several somite levels
are representedwithmultiple symbols. The fatemap is based on 27macrophage clones, 41 erythrocyte clones, 16 neutrophil clones, and 12 thrombocyte clones.
These clones include all that were later verified by in situ hybridization.
(H and I) Verification of in vivo bloodmorphology by one- or two-color in situ hybridization at 36 hr. (H) Amultilineage erythrocyte, neutrophil, and thrombocyte clone
(red fluorescence) that was visualized for coexpression of hbbe2, an erythrocyte-specific marker (green fluorescence), and mpx, a neutrophil-specific marker
(NBT/BCIP purple substrate). Left panel, the white-light image shows two lineage-labeled neutrophils (arrows). Inset, same cells showingmpx expression alone.
Right panel, the UV image shows two lineage-labeled erythrocytes (arrowheads) and a clonally related thrombocyte (hbbe2-negative; right of upper erythrocyte).
Theneutrophil portionof the clone isout of focus (arrows). (I) Aunilineagemacrophageclone (redfluorescence) thatwasvisualized for coexpressionof lcp, amacro-
phage marker (NBT/BCIP purple substrate). The white-light image shows three lineage-labeled macrophages (arrows) and two macrophages not in the clone.pronephros (12%; rows 6 and 7; Table 1). However, it was rare
(1%; row 9; Table 1) for a clone to give rise to both blood and
pronephros in the absence of endothelium, whereas endothe-
lium-only clones were observed frequently (15%; rows 1 and 10;
Table 1). These results indicate that most cells in themid-blastula
are not yet restricted to a single fate in the intermediate meso-
derm. We also suggest that these results indicate that there is
an initial decision between hematopoietic fate (blood and endo-
thelium) versus one leading to the production of pronephros
and/or endothelium.
In contrast to the data obtained from mid-blastula-derived
clones, gastrula-derived clones (Table 1; n = 34) tended to be
restricted to a single fate, consistent with earlier fate mapping
studies (Kimmel et al., 1990; Melby et al., 1996; Shih and Fraser,
1995). Thus, the majority of gastrula clones gave rise to blood
only (29%; rows 3 and 13; Table 1), endothelium only (26%;
rows 1 and 10; Table 1), or pronephros only (26%; row 4; Table
1). However, a substantial number of clones (18%; rows 2, 11,
and 12; Table 1) still gave rise to blood and endothelium together,
and if one excluded those containing macrophages, this amount
(15%; rows 11 and 12; Table 1) was remarkably consistent with
the previously reported percentage of cells regarded to be the
zebrafish hemangioblast in the early gastrula (Vogeli et al., 2006).
Because gastrula clones never gave rise to blood or endothe-
lium along with pronephros (Table 1), our data suggest that
pronephric identity is established as a single fate-producingDevlineage shortly before gastrulation. One other fate appears to
become established by gastrulation. Clones containing only
macrophages were highly prevalent (89%) when established in
the gastrula, but less prevalent (11%) when established at the
mid-blastula stage (compare rows 2 and 3 between Table 1).
Such was not the case for clones containing other blood cell
types, as erythrocytes, neutrophils, and thrombocytes still had
a marked tendency to share a lineage with each other as well
as with endothelial cells (Table 1).
Neutrophils and Thrombocytes Are Derived
from Ventral, Erythrocyte-Producing Lineages
Our fatemap data show that a labeled ventral clone can gave rise
tomultiple bloodcell types by 48 hr, namely, erythrocytes, throm-
bocytes, and neutrophils (rows 7, 9, 12, and 14; Table 1). How-
ever, in earlier observations at 26 hr, erythrocytes and macro-
phages appeared to be the only blood types present. One
possibility is that neutrophils and thrombocytesderive fromdefin-
itive blood cells sharing lineage with primitive erythrocytes. To
test this hypothesis, we reinvestigated where blood clones were
located at 24 hr, before bloodmigrates out of the ICM and begins
to circulate; we then followed these clones for the next 12 hr.
We found that clones in the anterior portion of the ICM (somite
levels 6–8) produced exclusively erythrocytes. Clones in the
remainder of the ICM, aswell as clones in thePBI, oftenproduced
neutrophils and/or thrombocytes in addition (Figure 2E). Withoutelopmental Cell 16, 744–755, May 19, 2009 ª2009 Elsevier Inc. 747
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nate from Both the Dorsal and Ventral
Gastrula
(A–E) Examples of individual derivatives. (A)
Macrophages, (B) erythrocytes and thrombo-
cytes, (C) neutrophils, (D) endothelial cells, and
(E) pronephric cells. da, dorsal aorta; e, erythro-
cytes; sv, segmental vein; t, thrombocytes. Arrows
indicate cellular protrusions.
(F–L) 6 hr gastrula fate maps. Clones that included
(F) macrophage cells, (G) just erythrocyte cells, (H)
both erythrocyte and neutrophil cells, (I) both
erythrocyte and thrombocyte cells, (J) endothelial
cells, and (K) pronephric cells. (L) Summary hema-
topoietic fate map. Superimposed symbols show
individual clones that gave rise to multiple fates.
The half-green/half-blue symbol indicates the
four clones that included all three ventral-derived
blood fates (erythrocytes, neutrophils, and throm-
bocytes). Some of the blood clones depicted on
the fate maps were also later verified by in situ
hybridization.exception, either of these two fates only derived from ventral
clones that included erythrocytes (Figures 3Hand3I). Inmultiline-
age clones, neutrophils and erythrocytes formed, on average,
a 1:9 ratio, whereas thrombocytes and erythrocytes formed, on
average, a 1:4 ratio. It was also possible for all three ventral blood
types to be present together in a single clone (Figures 2H and 3L).
Thus, it is unlikely that neutrophils and/or thrombocytes are solely
derived from the earliest definitive blood progenitors. Further-
more, clones that included two or three of these ventrally derived
blood types often also included endothelial cells (Figure 3L), sug-
gesting that the ventral hemangioblast progenitor identified by
Vogeli et al. (2006) is perhaps multipotent.
Further examination of these clones revealed that thrombo-
cytes were already discernable in the ICM at 24 hr. Such labeled
cells did not enter circulation immediately, but many were circu-
lating by 30 hr (Figure 3B). Neutrophils began to appear in the
viteline vein of the yolk sac and within other blood vessels
(Figures 2F–2H and 3C) in the interval between 24 and 36 hr.
This period correlated with the rapid expansion of the labeled
erythrocytes within our clones.
We confirmed the identity of these cells by in situ analysis
(Figures 2H and 2I). As shown in Table 2, we had an error rate
for erythrocytes of 3%, some of which was likely due to cells
resembling an erythrocyte at 36 hr, but not yet having differenti-
ated enough to express the hbbe2 globin gene (Brownlie et al.,
2003). With respect to neutrophils, the majority of cells (93%)
identified as neutrophils expressed mpx, a gene specific to
neutrophils (Bennett et al., 2001; Lieschke et al., 2001), and never
hbbe2 nor lcp, which at this time is mainly expressed in only
macrophage cells (Bennett et al., 2001; Herbomel et al., 1999).
Although the error rate for neutrophils is higher than that of eryth-
rocytes, in situ analysis never disqualified a clone we determined
in vivo to contain at least some neutrophil cells. This is because
we were only occasionally in error on the precise number of748 Developmental Cell 16, 744–755, May 19, 2009 ª2009 Elsevier Ineutrophils within a clone, but never on whether a clone con-
tained neutrophils or not. Thrombocytes have no specific early
markers, but they are known to not express hbbe2 or mpx (Lin
et al., 2005); as shown in Table 2, 100% of the cells that we iden-
tified as thrombocytes in vivo adhered to these parameters.
To corroborate our data obtained from single-cell blastula
clones, we employed a different method of marking cells by
using the UV-induced green-to-red photoconversion of the fluo-
rescent Kaede protein (Ando et al., 2002). This strategy allowed
us to test whether single blood cells at the onset of circulation
continue to divide and/or are multipotent when it is otherwise
difficult to label blood by traditional lineage tracer techniques.
In brief, we intracellularly injected single cells with Kaede
mRNA in the mid-blastula-stage embryo and at 24–26 hr,
selected embryos with clones of Kaede-expressing cells in the
appropriate tissue, and then photoconverted a single cell to
produce red fluorescence in that cell and all its progeny.
To avoid the possibility of labeling definitive blood believed to
be lurking—not yet circulating—in the PBI (Bertrand et al., 2007),
we initially photoconverted only the earliest circulating blood
cells in the viteline vein of the yolk sac, i.e., cells that we would
otherwise have been identified as erythrocytes (Figures 4A–
4C). In later experiments, we targeted noncirculating cells in
the ICM. We found that photoconverted cells (n = 10) usually ex-
hibited robust division rates; in nine of these clones, there were
10–20 red-labeled blood cells the next day, suggesting that
individual cells divide every 5–6 hr. This rapid cell cycle length
is supported by the observation that 7 hr after marking, one clone
already had 3 red-labeled blood cells, indicating that at least two
doublings had occurred during this interval. Not all photocon-
verted cells continued to divide (n = 1); thus, some blood has
dropped out of the cell cycle by this time. Of the nine photocon-
verted cells that multiplied, two included neutrophils as well
as erythrocytes among their progeny (Figures 4D and 4E). Innc.
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36 hr Fates
Row Location Pronephros Endothelial Cells Erythrocytes Neutrophils/Thrombocytes Macrophages Number of Clones
Blastula Clones
1 Dorsal X 5
2 X X 8a
3 X 3a
4 Ventral X 0
5 X X 12b
6 X X X 2c
7 X X X X 6d
8 X X 0
9 X X X 1
10 X 5
11 X X 9e
12 X X X 6a
13 X 4e
14 X X 6a,c
Gastrula Clones
1 Dorsal X 4
2 X X 1
3 X 8
4 Ventral X 9
5 X X 0
6 X X X 0
7 X X X X 0
8 X X 0
9 X X X 0
10 X 5
11 X X 2
12 X X X 3
13 X 2
14 X X 0
a Two of these clones also made endoderm.
b Three of these clones also made muscle.
cOne of these clones also made muscle.
d Two of these clones also made muscle or heart.
eOne of these clones also made endoderm.agreement with our above-described ICM fate map (Figure 2E),
one of these clones was descended from a cell marked in the
viteline vein just as it was entering circulation (Figures 4A–4C),
whereas the other was descended from a cell marked in the
posterior ICM. Unlike our results from the blastomere labeling
studies reported above, we did not observe labeled thrombo-
cytes among the photoconverted progeny, possibly because
these cells no longer share lineages with erythrocytes at this later
time. Taken together, these two different marking schemes
demonstrate that neutrophils, as well as thrombocytes, originate
from progenitors in the ventral gastrula that are robustly prolifer-
ative, share lineages with primitive erythrocytes, and can remain
multipotent rather late in development.
In notable contrast to the ventrally derived blood, the dorsally
derived blood gave rise to only macrophages, as assayed byDevboth morphology and in situ hybridization of labeled cells
(Figures 2I and 3A; Table 2). Hence, no other primitive blood
type appears to derive from the RBI (Figure 2E). Macrophages
divided infrequently relative to the erythrocyte lineage, and
Kaede photoconversion of individual macrophage cells at 26 hr
(Figures 4F–4H) either showed that the cell did not divide further
(n = 2) or gave rise to two or three red-labeled macrophage
progeny the next day, usually located in the mesenchyme
outside the circulatory system (Figure 4I; n = 7).
Blood Cells Derive from a Small Pool of Gastrula
Progenitors
Although blood cells are abundant at 1 day of development, they
appear to arise from a relatively small founder population in the
blastula based on their infrequency in our entire fate map dataelopmental Cell 16, 744–755, May 19, 2009 ª2009 Elsevier Inc. 749
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can be calculated by comparing the number of progeny derived
from a single precursor cell labeled during fate map analysis to
the total number of that cell type found in the embryo at a partic-
ular stage. For example, in our experiments, a single dorsal
blood progenitor labeled at the mid-blastula stage will give rise
to an average of 6 ± 2macrophage progeny by 26 hr. By counting
the total number of cells that express the macrophage marker
lcp1 in an embryo, we observed a total population of 151 ± 37
macrophage cells present at 26 hr. These numbers allow us to
estimate the number of dorsal blood progenitors at the mid- to
late-blastula stage to be in the range of 14–47 cells, with the
median being 31 cells. For the ventral blood progenitors, we
counted cells expressing hbbe2 andmpx at 26 hr, arriving at esti-
mates of 594 ± 96 erythrocytes and 67 ± 2 neutrophils. (This ratio,
approximately nine erythrocytes to one neutrophil, was equiva-
lent to the 9:1 ratio found in our clonal analysis reported above.)
Using the total cell counts of erythrocytes and neutrophils
considered together, compared to the clonal expansion size
of a single ventral blood progenitor giving rise to 26 ± 7 circu-
lating cells at 26 hr, we calculated a founder population size in
the range of 17–40 cells, with a median of 29 cells for the ventral
population.
As an independent test of these calculations, we checked the
numbers of blood cells produced in the cell cycle-defective
harpy (hrp) mutant (Kane et al., 1996), which we have confirmed
by complementation and sequence analysis (unpublished data)
to harbor a mutation in the zebrafish homolog of emi1 (Zhang
et al., 2008). At the mid-gastrula stage, cells in the hrp mutant
begin to endocycle, replicating their DNA each S phase, but do
not undergo further cell divisions. Despite this defect, we have
confirmed by lineage tracing analysis that cells in the mutant,
including within the blood lineage, survive and eventually differ-
entiate (R.M.W. and D.A.K., unpublished data). In 26 hr hrp
mutants, we found cells that expressed the macrophage marker
lcp1 (Figure 5B), the erythrocyte marker hbbe2 (Figure 5D), and
the neutrophil marker mpx (Figure 5F). In general, the mutant
cells labeled by these markers resembled larger versions of their
wild-type counterparts (Figures 5A, 5C, and 5E).
Table 2. Verification of In Vivo-Identified Cells with In Situ
Markers
Total Number Ratio of Cells In Situ/In Vivo
In Vivo Identification Cells Embryos lcp hbbe2 mpx
Macrophage 99 19 90/91a not done 0/21
Erythrocyte 590 24 0/160 571/590b 0/344
Neutrophil 39 12 0/11 0/34 26/28c
Thrombocyted 55 10 not done 0/55 0/52
Clones were examined at 24 hr and again between 30 and 36 hr before
being fixed and processed for in situ hybridization. In general, but not
always, ventral clones were examined with two different riboprobes.
aOf 91 labeled cells identified as macrophages, 90 expressed the marker
lcp, which is specific for macrophages and possibly other white blood
cells.
b The marker hbbe2 is specific to erthrocytes.
c The marker mpx is specific to neutrophils.
d Thrombocytes do not express the thrombocyte-specific marker cd41
until 48 hr.750 Developmental Cell 16, 744–755, May 19, 2009 ª2009 ElsevierIn Figures 5A–5F, embryos are shown at 26 hr. However,
because themutants do not start normal circulation—and some-
times begin to necrose—we fixed embryos slightly earlier for cell
counts. In all cases, at 24 hr (Figure 5G) hrp mutant blood cells
were fewer in number than wild-type blood cells: Macrophages
were reduced from 154 ± 4 to 30 ± 2 cells, a 53reduction.
Erythrocytes were reduced from 453 ± 9 to 41 ± 2 cells, an
113 reduction, and neutrophils were reduced from 64 ± 3 to
19 ± 1 cells, a 33 reduction. This number for macrophages is
very similar to the above-calculated number from counts and
clonal expansion estimates, confirming our estimate of 31
dorsal blood progenitors. The counts of erythrocytes and neutro-
phils considered together is 23 higher than our estimate given
above from clonal analyses of 29 ventral gastrula founders.
However, because our fate map clones were established near
Figure 4. Not All Blood Is Committed to a Unipotential Lineage at
26 hr
(A–E) Single circulating blood cells give rise to neutrophil and erythrocyte
progeny. (A–C) A newly photoconverted blood cell (arrow), within a ventral
gastrula-derived clone. (A) Red wavelength, (B) green wavelength (note the
other blood cells), and (C) composite image. (D and E) The resulting red-
labeled clone at 48 hr included (D) circulating erythrocytes and (E) two neutro-
phils attached to the lumen of a blood vessel.
(F–I) Single macrophage cells give rise to macrophage progeny. (F–H) High-
magnification view of an individual macrophage (arrow) in the process of being
photoconverted from (F) green to (G) red. Nearby, another green-labeled
macrophage (upper left panel) is preparing to divide. (H) Low-magnification
view of the entire Kaede clone showing the newly photoconverted macro-
phage (arrow) among other green-labeled macrophages and out-of-focus
endoderm and endothelium. (I) The resulting red-labeled clone at 48 hr was
solely two macrophages near a blood vessel. Another green-labeled macro-
phage is out of focus.Inc.
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happens during mid gastrulation, we assume that this difference
is due to a round of mitotic activity normally occurring between
these two developmental stages. This assumption is in line
with our observation that ventral blood progenitors display
more robust division rates than their dorsal counterparts.
DISCUSSION
Primitive Hematopoietic Progenitors Derive
from Hierarchical Lineages
During definitive hematopoiesis in mammals, fates appear in
a chronological and hierarchical order (Graf, 2008; Orkin and
Zon, 2008; Reya et al., 2001). We observe a similar phenomena
during development of the primitive hematopoietic lineage of
zebrafish, summarized in Figure 6A. Based upon the types and
timing of restrictions observed within our blood-containing
clones, the earliest hierarchical fate distinction that occurs is
between a pronephros fate versus a blood/endothelial fate.
This segregation of pronephros-only lineages occurs in ventrally
Figure 5. Blood Formation in the Cell Cycle-Arrested Mutant harpy
(A–F) (A and B) Macrophage cells, (C and D) erythrocyte cells, and (E and F)
neutrophil cells in wild-type and harpy (hrp) siblings. Note the super-sized cells
in the hrp mutant.
(G) The approximate number of blood cells found at 24 hr. Error bars show
SEM. For each blood type, a total of ten ormorewild-type andmutant embryos
were counted.Devlocated cells between the mid-blastula stage and the onset of
gastrulation and is evidenced by the fact that many blood- and
endothelium-containing clones initiated at mid-blastula stages
also contained pronephros cells, whereas clones initiated at
gastrula stages were never observed to share lineages with
pronephric tissues (compare rows 4–9; Table 1). Interestingly,
this observation correlates with previous studies suggesting
that the hematopoietic progenitors of many vertebrate embryos
derive from mesoderm that first activates a kidney program of
development (Davidson and Zon, 2004). Although many of the
mid-blastula established clones shared lineages with other
mesodermal tissues or even endodermal tissues (Table 1), we
did not observe hematopoietic-containing clones to include
heart cells, even though their fate map territories overlap (Kee-
gan et al., 2004; Kimmel et al., 1990; Stainier et al., 1993; Warga
and Nu¨sslein-Volhard, 1999).
A second hierarchical distinction presents itself sometime at
the onset of gastrulation, separating blood and endothelial fates.
Notably, these observations correlate with clonal studies
showing the existence of cells called hemangioblasts in the
mammalian gastrula that can generate both erythroid and
vascular cells, at least in vitro (Huber et al., 2004; Kennedy
et al., 2007; Tober et al., 2007), which are largely absent by the
time of blood island development (Yokomizo et al., 2007). Cells
fitting the description of hemangioblasts or hemangioblast
precursors (i.e., those cells giving rise to endothelium, blood,
and one other fate) constituted the majority (62%, rows 2, 6, 7,
11, and 12; Table 1) of the blood-producing clones (rows 2, 3,
6–9, and 11–14; Table 1) at the mid-blastula stage. By the late-
blastula/early-gastrula stage, the numbers of such cells (rows
2, 11, and 12; Table 1) in our data appear to drop by more than
a third of the numbers observed at the mid-blastula stage
(38% of the total blood-producing clones; rows 2, and 3, and
11–13; Table 1), whereas the percentage of blood-only-
producing clones is now the majority.
A previous study by Vogeli et al. (2006) reported the inability to
consistently find evidence for a hemangioblast or hemangioblast
precursor before the onset of gastrulation and concluded that
erythrocytes and endothelial cells rarely derived together (even
with other fates) until the onset of gastrulation. One interpretation
from Vogeli et al. would be that a hemangioblast represented
a new entity that arises de novo at the onset of gastrulation.
Our fate map data from various different stages of development,
as described above and summarized in Table 1, do not support
this interpretation. Although we do not fully understand the
reason for the differences in our study and that of Vogeli et al.,
we interpret our observations to be consistent with the hypoth-
esis that the embryonic blood cell lineages of zebrafish are
derived in a progressively restricted manner (Figure 6A) similar,
at least in form, to the hierarchical lineage that is thought to
give rise to definitive blood cell types.
Erythrocytes and Macrophages Are Derived
from Distinct Regions of the Gastrula
In the original zebrafish fate map papers, blood was classified as
being derived exclusively from the ventral side of the gastrula;
however, the designation of ‘‘blood’’ used by these authors
appears to have been applied mainly, if not solely, to primitive
erythrocytes (Kimmel et al., 1990; Warga and Nu¨sslein-Volhard,elopmental Cell 16, 744–755, May 19, 2009 ª2009 Elsevier Inc. 751
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Blood
(A) Hierarchy of fates occurring in the dorsal and
ventral hematopoietic lineages. The timeline
depicts when restrictions occurred in our clonal
analysis.
(B) The previous view of primitive blood develop-
ment.
(C) A revised view based on findings described in
this work. The hierarchy for the ventral blood
lineage shown here is purely hypothetical.
D, dorsal; ICM, intermediate cell mass; RBI, rostral
blood island; V, ventral.1999). Subsequent blood fate map papers made a distinction
between erythrocytes and macrophages, but also reported
that zebrafish macrophages derived from the ventral side of
the embryo, sometimes even from a progenitor that also gave
rise to erythrocytes (Herbomel et al., 1999). Thus, the current
state of knowledge from the literature (summarized in Figure 6B)
was that a common progenitor cell on the ventral side of the ze-
brafish gastrula gives rise to progeny potent for either macro-
phage or erythrocyte fate depending upon which blood island
it populates or which transcription factors it expresses (Galloway
et al., 2005; Rhodes et al., 2005). We note that a common
progenitor has also been reported to exist during primitive hema-
topoiesis in mammals (Kennedy et al., 2007; Palis et al., 1999).
In this present study, we now show that not all embryonic
blood of the zebrafish derives from a common gastrula location.
Rather, like the recently revised fate map of Xenopus (Lane and
Sheets, 2006), blood originates around the entire circumference
of the gastrula-stage embryo, except at the dorsal midline
(Figure 6C). In agreement with previous reports, we show that
erythrocytes derive from the ventral half of the gastrula (Kimmel
et al., 1990; Vogeli et al., 2006; Warga and Nu¨sslein-Volhard,
1999) and later from the ICM (Detrich et al., 1995; Long et al.,
1997). However, in contrast to previous reports (Herbomel
et al., 1999), our data show that macrophages derive exclusively
from the dorsal half of the gastrula. Moreover, we never
observed a clone labeled at the mid-blastula or gastrula stages
that gave rise to both erythrocytes and macrophages. We
suggest that the different results obtained between this and
previous studies may be due to the time at which individual cells
were labeled. Previouswork to fatemap themacrophage lineage
(Herbomel et al., 1999) was based on cell labeling at the 16-cell
stage and correlating cell fates in the 1 day embryo. As reported
by a number of studies, there is no fixed relationship to dorso-
ventral position at the 16-cell stage, nor correlation to particular
fates due to the highly variable patterns of cell division that occur
after the fifth cleavage (Kimmel and Law, 1985a; Kimmel and
Warga, 1987). In addition, clones established at the 16-cell stage
are extremely large and scatter widely between unlabeled cells
due to the cell movements that occur during early epiboly
(Kimmel and Law, 1985b; Warga and Kimmel, 1990; Wilson
et al., 1995). Because we labeled cells around the 2K-cell stage,
our clones were small (usually nomore than four cells); therefore,
it was easier to verify the actual dorsoventral position of the clone
at the gastrula stage. In summary, our data indicate that the iden-
tity of a macrophage- versus an erythrocyte-producing lineage
can be accurately predicted solely upon its dorsoventral position752 Developmental Cell 16, 744–755, May 19, 2009 ª2009 Elsevierwithin the mid-blastula-/early-gastrula-stage embryo. Further-
more, because dorsoventral position in the gastrula correlates
approximately with later anteroposterior position in the embryo
(Warga and Nu¨sslein-Volhard, 1999), our finding that primitive
macrophages derive from more dorsally located cells concurs
with their later association in amore anterior blood island relative
to the primitive erythrocyte population.
Primitive Neutrophils, Thrombocytes, and Erythrocytes
Share a Common Lineage
By intracellular labeling of early blastomeres, we found that
neutrophils and thrombocytes derived from the same lineages
as primitive erythrocytes. These results demonstrate that some
hematopoietic progenitors are multipotent rather than unipotent
during the initial primitive wave. The multipotent progenitors are
originally located on the ventral side of the gastrula-stage
embryo from which they later become positioned along the
length of most of the ICM before entering circulation. In the
case of zebrafish thrombocytes, our data corroborate a recent
report showing that the mammalian source of this cell type in
the embryonic mouse frequently derives from lineages that
also include primitive erythrocytes (Tober et al., 2007). In this
study, we additionally activated the Kaede molecule within indi-
vidual blood cells at 26 hr to support the surprising finding that
a population of zebrafish neutrophils, a white blood cell, could
also be generated after the first day of development, from what
appear to be primitively derived red blood cells, namely, circu-
lating erythrocytes. Alternatively, this last result could also be in-
terpreted as showing that a subpopulation of primitive blood,
which cannot be distinguished superficially from an erythrocyte,
must retain multipotency relatively late in development, even up
to the beginning of definitive blood formation.
We note here that neutrophils have also been reported to be
derived from the primitive macrophage lineage by 36 hr (Le
Guyader et al., 2007). Like itsmammalian counterpart, the zebra-
fish neutrophil possesses myeloperoxidase granules, and a
number of studies agree that expression of myeloperoxidase
(mpx) reliably identifies embryonic neutrophil cells (Bennett
et al., 2001; Hall et al., 2007; Lieschke et al., 2001; Mathias
et al., 2006; Meijer et al., 2007). As our studies concentrated
upon the primitive blood lineages and therefore did not continue
far beyond the second day of development, we cannot be sure
whether the cell types identified as neutrophils by Le Guyader
et al. (2007) are in fact the same population of cells that we iden-
tified as embryonic neutrophils. However, when checked by
in situ hybridization at 36 hr, the cells we had identified asInc.
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phage gene lcp (99%), but they never expressed the neutro-
phil-specific gene mpx (0%), whereas those cells that we had
identified as neutrophils almost always expressed the mpx
gene (93%; Table 2). Therefore, within the time frame of primitive
hematopoiesis, we find no evidence for a linear relationship
between macrophages and neutrophils.
In summary, our data show that the ventral gastrula produces
some 30 or so multipotent progenitor cells that have the
capacity, perhaps due in part to their rapid division rate, to
generate not only all the primitive erythrocytes, but also the
earliest circulating thrombocytes and neutrophils. The dorsal
gastrula likewise produces about an equal number of 30 progen-
itor cells; however, these cells divide infrequently and, in terms of
a primitive blood cell fate, solely generate macrophages. Hence,
the ventral gastrula is not the sole provider of all blood lineages,
as had been previously thought, but rather there appears to be
two different mechanisms that correspond to both ventral and
dorsal positions within the early gastrula for producing the
primitive blood of zebrafish. In the future, it will be important to
determine the molecular mechanisms governing these separate
unipotent and multipotent programs as well as the precise rela-
tionships between different blood types in both the primitive and
definitive blood populations.
EXPERIMENTAL PROCEDURES
Embryos
For fate mapping, embryos were derived from crosses of wild-type strains. For
in situ analysis, embryos were derived from crosses of wild-type strains or of
identified hrpti245 heterozygotes.
Lineage Tracing and Fate Map Construction
Lineage tracing and fate map construction were adapted from those protocols
previously described (Warga and Nu¨sslein-Volhard, 1999). Briefly, an indi-
vidual blastomere was labeled between the 1K- and 4K-cell stages with
a 5% solution of lysinated rhodamine-dextran (70,000 MW; Invitrogen,
formerly Molecular Probes). At the stages indicated below, embryos were
oriented in 3% methyl cellulose in Daniaeu’s media and analyzed with a Zeiss
Axioplan microscope, VideoScope VS-2525 image intensifier, and VS2000N
Newvicon Camera. Images were stored directly onto a Power Macintosh
9600/350 running Cytos 3.0.1 software (Applied Scientific Instrumentation).
In the zebrafish, all embryonic fates derive from the deep cell portion of the
blastoderm, not from the outer enveloping layer (EVL) (Kimmel et al., 1990). The
segregation between the deep cell and EVL lineages occurs a cell cycle or two
after the mid- to late-blastula stages (Kimmel and Law, 1985a, 1985b), about
when our clones were established. At this time, a blastomere can divide to give
rise to two deep cells, two EVL cells, or to a combination of one deep cell plus
one EVL cell. We used this segregation to determine when a single-cell clone
(of deep cells) was established. For example, if at 40%–50% epiboly two
labeled deep cells were observed, this clone was established in the mid-blas-
tula stage. If, however, only one labeled deep cell was observed at 40%–50%
epiboly, as seen in Figure 2A, this clone was established in the late blastula,
i.e., the onset of gastrulation. For making the fate map, clones were examined
at 40%–50% epiboly, to determine the distance from the margin (Figure 2A),
and again at the shield stage, to determine distance from dorsal (Figure 2B).
Clones were reexamined from 24 to 48 hr of development to determine cell
fate (Figures 2F and 2G). Cell fate was assigned based on analysis of behavior
and morphology in the live embryo; typically, blood cells were analyzed for
5–10 min, and a portion of these clones was also processed for in situ hybrid-
ization to confirm cell fate (Table 2). In some embryos, we also examined which
blood island the clone located to (Figure 2C) or its precise location in a blood
island just before the onset of circulation (Figure 2E).DeveFor marking single cells at 26 hr, individual blastomeres in the 1K-cell stage
embryo were injected with a mixture of 1% phenol red and Kaede mRNA
(100 ng). As described above, the resulting clone was examined at 40%–
50% epiboly and the shield stage. At 26 hr, if the clone contained blood,
a single blood cell was photoconverted by changing the fluorescent spectrum
of the Kaede protein from green to red fluorescence (Ando et al., 2002) by
using 10 s pulses of 440 mm light. Photoconversion was done at 6303 on
a Zeiss Axioplan with a specially machined field diaphragm with a pinhole
aperture of less than 10 mm. Progeny of this red cell and the original green
clone continued to be monitored up to 48 hr of development.
In Situ Hybridization and Confirmation of Cell Fate
Embryos were fixed in 4% paraformaldehyde, and whole-mount RNA in situ
hybridization was carried out by using digoxigenin- or fluorescein-labeled
riboprobes (Jowett and Yan, 1996) following the protocol by Thisse et al.
(1993), with the following modifications: (1) after permeabilizing embryos
with MeOH, and before the Protinase K treatment, embryos were incubated
for 10 min in 0.6% H2O2 in PBS to quench endogenous Peroxidase activity,
(2) the Protinase K concentration was reduced to 0.25 mg/ml and digestion
time to no more than 5 min; and (3) after Protinase K treatment, embryos
were postfixed in fresh paraformaldehyde for at least 1.5 hr at room tempera-
ture. The second and third modifications decreased yolk sac loss, where most
of the blood cells reside once circulation commences.
For detection of the digoxigenin-labeled riboprobe, we used the alkaline
phosphatase-labeled anti-digoxygenin antibody (Roche, 1:5000) and a NBT/
BCIP purple substrate. For colocalization experiments involving marked
clones, we additionally probed with a fluorescein-labeled riboprobe that was
visualized by using a peroxidase-labeled anti-fluorescein antibody (Roche,
1:1000), followed by teramide signal amplification (fluorescein reagents were
kindly provided by Vicky Prince). To see the labeled clone within in situ-labeled
cells, it was necessary to amplify the fluorescent signal. Therefore, after in situ
hybridization, rhodamine-dextran-labeled cells were immunodetected with an
anti-tetramethylrhodamine antibody (Invitrogen, 1:500) and Alexa Fluor 555 or
488 goat anti-rabbit secondary antibodies (Invitrogen, 1:200). Embryos were
cleared in 70% glycerol and photographed on a Zeiss Axioplan with a Nikon
D1 or Sony F-707 digital camera.
We used spi1(Hsu et al., 2004; Lieschke et al., 2002), gata1 (Detrich et al.,
1995), lcp1 (Herbomel et al., 1999), mpx (Bennett et al., 2001; Lieschke
et al., 2001), and hbbe2 (Brownlie et al., 2003).
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